Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Blood Cancer Journal|July 30, 2025
The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphomaAnna De Bolòs, Maria Carreras-Caballé, Marta Sureda-Gómez, et al.
Blood|June 30, 2021
SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphomaPatricia Balsas, Luis Veloza, Guillem Clot, et al.
Blood|January 29, 2021
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma deathAna Domostegui, Suresh Peddigari, Carol A Mercer, et al.
International Journal of Cancer|November 24, 2018
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemiaEriong Lee-Vergés, Bola S Hanna, Haniyeh Yazdanparast, et al.
Blood|April 15, 2024
SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic featuresMarta Sureda-Gómez, Ingram Iaccarino, Anna De Bolòs, et al.
Plos One|July 9, 2011
Epigenetic activation of SOX11 in lymphoid neoplasms by histone modificationsMaria Carmela Vegliante, Cristina Royo, Jara Palomero, et al.
Scientific Reports|February 7, 2026
The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphomaElena María Fernández-Garnacho, Cristina Martínez-Muñoz, Ferran Nadeu, et al.
Blood|January 18, 2024
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphomaMohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, et al.
Cancer Research|February 4, 2010
Genomic and gene expression profiling defines indolent forms of mantle cell lymphomaVerònica Fernàndez, Olga Salamero, Blanca Espinet, et al.
Biomarker Research|July 23, 2026
Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine modelsSatishkumar Singh, Yuanfeng Wang, Anuvrat Sircar, et al.
Pageof 4